You are here

Article Text

Article menu

Download PDFPDF

Abstracts
Abstracts
Free

https://doi.org/10.1136/jitc-2022-ITOC9.abstracts

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Editors

    • Michael von Bergwelt (LMU, CCC, DKTK, Munich, Germany)

    • Sebastian Kobold (Ludwig-Maximilians-Universität, Munich, Germany)

    • Volkmar Nuessler (TZM, Munich, Germany)

    Scientific Committee

    Conference President

    • Michael von Bergwelt-Baildon (LMU, CCC, DKTK, Munich, Germany)

    Chairman of the Scientific Committee

    • Sebastian Kobold (Ludwig-Maximilians-Universität, Munich, Germany)

    • Volkmar Nuessler (TZM, Munich, Germany)

    Scientific Committee

    • Niroshana Anandasabapathy (Weill Cornell New York, NY, United States)

    • Michael Bergmann (Medical University Vienna, Austria)

    • Mascha Binder (Martin Luther University Halle-Wittenberg, Germany)

    • Marcus Bosenberg (Yale School of Medicine, New Haven, CT, USA)

    • Tanja D. de Gruijl (Cancer Center Amsterdam, The Netherlands)

    • Ulrich Jäger (Medical University of Vienna, Austria)

    • Sebastian Kobold (Ludwig-Maximilians-Universität, Munich, Germany)

    • Andreas Mackensen (Universitätsklinikum Erlangen, Medizinische Klinik 5, Erlangen, Germany)

    • Marcela Maus (Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA)

    • Chong-Xian Pan (Harvard Medical School, Boston, MA, United States)

    • Sine Reker Hadrup (Technical University of Denmark, Experimental & Translational Immunology, Lyngby, Denmark)

    • Pedro Romero (Translational Tumor Immunology Group, University of Lausanne, Switzerland)

    • Maya Saleh (Director Oncoimmunology Research, Department of Life Sciences and Health, University of Bordeaux, France)

    • José Saro (Vice-President, Global clinical Development, Adaptimmune Therapeutics, Abingdon, Oxfordshire, United Kingdom)

    • Marion Subklewe (Ludwig-Maximilians-Universität, Munich, Germany)

    • Eric Tartour (Hopital Européen Georges-Pompidou, Paris, France)

    • Giorgio Trinchieri (Center for Cancer Research, NCI, NIH, Bethesda, MD, United States)

    • Christoph Zielinski (Medical University of Vienna, Austria)